logo
Select company
Select metric
$ -53.12MNet Cash Flow - Investing
VS
Market
43
Sector
21
Industry
12
History
22
$ 10.38Close
$ 3.99 - $ 45.62 52-Week Range
Ticker Information

Ticker

ALGS

Company Name

ALIGOS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALIGOS THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALGS - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -53.12M
3/31/2025$ 26.3M
12/31/2024$ -18.28M
9/30/2024$ -38.26M
6/30/2024$ -48.66M
3/31/2024$ -63.65M
12/31/2023$ 44.98M
9/30/2023$ 56.59M
6/30/2023$ 89.08M
3/31/2023$ 54.1M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALIGOS THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ 32.76M.
  • Over the past 5 years, ALIGOS THERAPEUTICS INC's average CF - Investing has been $ -3.01M.
  • The median CF - Investing for ALIGOS THERAPEUTICS INC during this period was $ -7.63M
  • ALIGOS THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 89.08M.
  • The lowest CF - Investing recorded by ALIGOS THERAPEUTICS INC in the same timeframe $ -86.9M

ALIGOS THERAPEUTICS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
STTK : SHATTUCK LABS INC $ 45.78MCAMP : CAMP4 THERAPEUTICS CORP $ -542KNRXS : NEURAXIS INC $ -29.66KPYXS : PYXIS ONCOLOGY INC $ 57.77MNTRB : NUTRIBAND INC $ -52.28KDTIL : PRECISION BIOSCIENCES INC $ -487KDYAI : DYADIC INTERNATIONAL INC $ 771.78KADVM : ADVERUM BIOTECHNOLOGIES INC $ 45.65MPSTV : PLUS THERAPEUTICS INC $ -1.02MPLUR : PLURI INC $ 8.03M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

ALGS - Net Cash Flow - Investing, Last 5 years

$ -86.9M

Minimum

Jun 30, 2022

$ 89.08M

Maximum

Jun 30, 2023

$ -3.01M

Average

$ -7.63M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.3M with a standard deviation of $ 83.36M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.3M
median$ -6.38M
std$ 83.36M